A homozygous BMPR1B mutation causes a new subtype of acromesomelic chondrodysplasia with genital anomalies O Demirhan, S Türkmen, GC Schwabe, S Soyupak, E Akgül, D Taştemir, ... Journal of Medical Genetics 42 (4), 314-317, 2005 | 113 | 2005 |
Analysis of peripheral blood T‐cell subsets, natural killer cells and serum levels of cytokines in children with Down syndrome S Çetiner, O Demirhan, TC İnal, D Tastemir, Y Sertdemir International journal of immunogenetics 37 (4), 233-237, 2010 | 98 | 2010 |
Chromosome aberrations in a schizophrenia population O Demirhan, D Taştemir Schizophrenia research 65 (1), 1-7, 2003 | 79 | 2003 |
International Study on sagliker syndrome and uglifying human face appearence in severe and late secondary hyperparathyroidism in chronic kidney disease patients Y Sagliker, V Acharya, Z Ling, O Golea, A Sabry, K Eyupoglu, ... Journal of Renal Nutrition 18 (1), 114-117, 2008 | 41 | 2008 |
International evaluation of unrecognizably uglifying human faces in late and severe secondary hyperparathyroidism in chronic kidney disease. Sagliker syndrome. A unique … I Yildiz, Y Sagliker, O Demirhan, E Tunc, N Inandiklioglu, D Tasdemir, ... Journal of Renal Nutrition 22 (1), 157-161, 2012 | 39 | 2012 |
Alterations in p16 and p53 genes and chromosomal findings in patients with lung cancer: fluorescence in situ hybridization and cytogenetic studies O Demirhan, D Taştemir, S Hastürk, S Kuleci, İ Hanta Cancer epidemiology 34 (4), 472-477, 2010 | 33 | 2010 |
Genetic alterations of chromosomes, p53 and p16 genes in low-and high-grade bladder cancer D Abat, O Demirhan, N Inandiklioglu, E Tunc, S Erdogan, D Tastemir, ... Oncology letters 8 (1), 25-32, 2014 | 31 | 2014 |
Cytogenetic effects of ethanol on chronic alcohol users O Demirhan, D Taştemir Alcohol & Alcoholism 43 (2), 127-136, 2008 | 25 | 2008 |
Cytogenetic study of recurrent miscarriages and their parents E Tunç, O Demirhan, C Demir, D Taştemir Russian Journal of Genetics 43, 437-443, 2007 | 25 | 2007 |
A cytogenetic study in 120 Turkish children with intellectual disability and characteristics of fragile X syndrome O Demirhan, D Tastemir, RS Diler, S Firat, A Avci Yonsei medical journal 44 (4), 583-592, 2003 | 25 | 2003 |
A cytogenetic study in 120 Turkish children with intellectual disability and characteristics of fragile X syndrome O Demirhan, D Tastemir, RS Diler, S Firat, A Avci Yonsei medical journal 44 (4), 583-592, 2003 | 25 | 2003 |
Chromosomal fragile site expression in Turkish psychiatric patients D Taştemir, O Demirhan, Y Sertdemir Psychiatry research 144 (2-3), 197-203, 2006 | 23 | 2006 |
Thymoquinone could be protective against valproic acid‐induced testicular toxicity by antioxidant and anti‐inflammatory mechanisms M Savran, H Ascı, İ Armagan, Y Erzurumlu, S Azırak, M Kaya Ozer, ... Andrologia 52 (7), e13623, 2020 | 21 | 2020 |
Prevalence and molecular analysis of β-thalassemia in Adiyaman, Turkey A Genc, D Tastemir Korkmaz, M Buyukleyla, M Celiker Hemoglobin 36 (2), 131-138, 2012 | 21 | 2012 |
Polymorphisms in NRAMP1 and MBL2 genes and their relations with tuberculosis in Turkish children HA Solğun, D Taştemir, N Aksaray, I Inan, O Demirhan Tuberk Toraks 59 (1), 48-53, 2011 | 19 | 2011 |
Detection of parental origin and cell stage errors of a double nondisjunction in a fetus by QF-PCR AI Guzel, O Demirhan, A Pazarbasi, FT Ozgunen, S Kocaturk-Sel, ... Genetic Testing and Molecular Biomarkers 13 (1), 73-77, 2009 | 18 | 2009 |
Risperidone-induced renal damage and metabolic side effects: the protective effect of resveratrol S Bilgiç, DT Korkmaz, S Azirak, AN Güvenç, N Kocaman, MK Özer Oxidative medicine and cellular longevity 2017, 2017 | 17 | 2017 |
Chromosomal fragile sites in schizophrenic patients O Demirhan, D Tastemir, Y Sertdemir Russian Journal of Genetics 42, 810-817, 2006 | 17 | 2006 |
Association of the Nramp1 gene polymorphisms and clinical forms in patients with tuberculosis. I Hanta, D Tastemir-Korkmaz, O Demirhan, D Hanta, S Kuleci, ... Bratislavske Lekarske Listy 113 (11), 657-660, 2012 | 16 | 2012 |
The protective effect of resveratrol against risperidone-induced liver damage through an action on FAS gene expression. S Azirak, S Bilgic, DT Korkmaz, AN Guvenc, N Kocaman, MK Ozer General Physiology & Biophysics 38 (3), 2019 | 14 | 2019 |